Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Reiterates Outperform on Compugen, Maintains $8 Price Target

Oppenheimer analyst Mark Breidenbach reiterates Compugen (NASDAQ:CGEN) with a Outperform and maintains $8 price target.
byBenzinga Newsdesk
February 28, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Mark Breidenbach reiterates Compugen (NASDAQ:CGEN) with a Outperform and maintains $8 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts